Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1680
    +0.0023 (+0.20%)
     
  • GBP/USD

    1.2493
    -0.0018 (-0.15%)
     
  • Bitcoin GBP

    51,081.58
    -575.67 (-1.11%)
     
  • CMC Crypto 200

    1,328.24
    -68.30 (-4.89%)
     
  • S&P 500

    5,110.88
    +62.46 (+1.24%)
     
  • DOW

    38,299.55
    +213.75 (+0.56%)
     
  • CRUDE OIL

    83.80
    +0.23 (+0.28%)
     
  • GOLD FUTURES

    2,348.40
    +5.90 (+0.25%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

3 Undervalued Biotechs Worth Adding to Your Watch List

3 Undervalued Biotechs Worth Adding to Your Watch List

If you're like me, your investment watch list is overflowing with dozens of stocks and price alerts. Let's examine three biotechs trading at lower than average valuations and consider whether they might be worth putting on your watch list. Supernus Pharmaceuticals (NASDAQ: SUPN) makes drugs that treat disorders of the central nervous system, including epilepsy and Parkinson's disease.